Paul Weishaar, MD
Retina Specialist · Wichita, KSNPI 1548261696
Payments from drug & device makers
Across 274 payments — averaging $2284.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Genentech, Inc.$610K
- US Retina LLC$7K
- Genentech USA, Inc.$2K
- Dutch Ophthalmic, USA$2K
- AbbVie$928
- Apellis Pharmaceuticals, Inc.$805
- plus $4K from 23 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Genentech, Inc. | 54 | $610,235 |
| US Retina LLC | 11 | $6,800 |
| Genentech USA, Inc. | 49 | $2,052 |
| Dutch Ophthalmic, USA | 1 | $1,500 |
| AbbVie(2 entities) | 34 | $928 |
| Apellis Pharmaceuticals, Inc. | 12 | $805 |
| ANI Pharmaceuticals, Inc. | 12 | $406 |
| Alimera Sciences, Inc. | 15 | $400 |
| Regeneron Healthcare Solutions, Inc. | 14 | $350 |
| Carl Zeiss Meditec USA, Inc. | 2 | $347 |
| Astellas Pharma US Inc | 9 | $291 |
| Eyepoint US, Inc. | 6 | $266 |
| Alcon | 3 | $223 |
| Novartis | 8 | $218 |
| Bausch & Lomb Americas Inc. | 5 | $178 |
| Sandoz | 4 | $123 |
| Coherus Oncology, Inc. | 5 | $97 |
| Biogen | 4 | $95 |
| Amgen(2 entities) | 5 | $88 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 6 | $87 |
| Topcon Healthcare Solutions, Inc. | 1 | $78 |
| Mallinckrodt Hospital Products Inc. | 4 | $70 |
| Glaukos Corporation | 1 | $70 |
| Mallinckrodt Enterprises LLC | 4 | $61 |
| Carl Zeiss Meditec, Inc. | 1 | $58 |
| Harrow Eye, LLC | 1 | $24 |
| Carl Zeiss Meditec AG | 1 | $19 |
| Aerie Pharmaceuticals, Inc. | 1 | $19 |
| Topcon Healthcare, Inc. | 1 | $10 |
How this compares
Too few retina specialist providers in Kansasto place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other retina specialist in Wichita
- Alan HromasWichita$23K
- Kumar DallaWichita$14K
- Michael VarenhorstWichita$10K
- David ChackoWichita$8K
- Brooke NesmithWichita$6K
- Charles BeckWichita$4K
- Thomas WoltjerWichita$2K
- Abraham PouloseLeawood$282K
- Javed SayedLeawood$8K
- Mary ChampionPrairie Village$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.